Patents by Inventor Jiunn Teo

Jiunn Teo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11925736
    Abstract: Dialyzer systems can consolidate multiple technologies and functionalities of blood treatment systems in a significantly integrated fashion. For example, this disclosure describes dialyzer systems that include a magnetically driven and magnetically levitating pump rotor integrated into the dialyzer. Such a dialyzer can be used with treatment modules that include a magnetic field-generating pump drive unit. In some embodiments, the dialyzers include pressure sensor chambers with flexible membranes with which corresponding pressure transducers of the treatment modules can interface to detect arterial and/or venous pressures.
    Type: Grant
    Filed: November 12, 2020
    Date of Patent: March 12, 2024
    Assignees: Fresenius Medical Care Deutschland GmbH, Fresenius Medical Care Holdings, Inc.
    Inventors: Massimo Earl Fini, Lynn E. Jensen, Alexander Heide, Dejan Nikolic, Arne Peters, Christoph Wiktor, Marina Wenke, Tommy Huang, Dacey John Ryan, Stefan Kreber, Lothar Leick, Dzhuney Terzi, Hendrik Therre, Manfred Weis, Alain Veneroni, Reinhold Reiter, Michele Marini, Davide Maria Benelli, Brad Yang, Jiunn Teo
  • Patent number: 11883784
    Abstract: A method is disclosed for forming a microporous membrane that incorporates an additive having low water solubility at the membrane's active surface from a precipitation fluid. The incorporated additive at the membrane's active surface can improve one or more of the membrane's hydrophilicity, wettability, anti-fouling behavior, blood compatibility, and stability over long periods of use or repetitive use. The microporous membrane with this modified active surface can be a hollow fiber, flat sheet, or other self-supporting shape. The microporous membranes can be used for membrane filtering or a solute and/or solvent exchange process, which involve contacting aqueous-based fluid or blood with the microporous membrane, such processes for dialysis, blood oxygenation, or blood separation filtering, or other processes.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: January 30, 2024
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Praveen Kosaraju, Monica P. Hall, Jiunn Teo
  • Publication number: 20220362717
    Abstract: The present invention relates to a method to make polymeric membranes that are preferably useful in dialysis, wherein the method conducts at least one membrane-forming step and/or post-forming processing step with the use of sonication. Polymeric membrane, such as polymeric hollow fiber membrane, having improved one or properties are further described.
    Type: Application
    Filed: May 10, 2022
    Publication date: November 17, 2022
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Brodie SCHWINN, Jiunn TEO
  • Patent number: 11499016
    Abstract: A polysulfone-urethane copolymer is disclosed, which can be used as a membrane polymer, e.g., a matrix polymer, a pore forming agent, or both, while enhancing a membrane's blood compatibility. Methods are disclosed for forming the copolymer and incorporating the copolymer in membranes (e.g., spun hollow fibers, flat membranes) and other products.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: November 15, 2022
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Geoffrey Russell, James White, Jiunn Teo, Kevin Hudson, Monica Hall, Praveen Kosaraju
  • Publication number: 20220133967
    Abstract: A hollow fiber membrane and methods of making the hollow fiber membrane are described. The membrane includes a hydrophobic polymer such as polysulfone, a hydrophilic polymer such as polyvinylpyrrolidone (PVP), and a fluropolymer additive, and optionally a stabilizer, for instance, to stabilize the fluoropolymer additive in the membrane, particularly during conditioning or E-beam sterilization or both. Further conditioning improvements to membrane manufacturing are disclosed. The membrane may be incorporated into a dialysis filter for use in hemodialysis and related applications. The membrane has improved hemocompatibility, charge stability, or middle molecule clearance compared to conventional membranes. Also disclosed is a method of evaluating membrane charge stability.
    Type: Application
    Filed: October 28, 2021
    Publication date: May 5, 2022
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Hui SHAO, Jiunn TEO, Chih-Hu HO
  • Publication number: 20210245108
    Abstract: A method is disclosed for forming a microporous membrane that incorporates an additive having low water solubility at the membrane's active surface from a precipitation fluid. The incorporated additive at the membrane's active surface can improve one or more of the membrane's hydrophilicity, wettability, anti-fouling behavior, blood compatibility, and stability over long periods of use or repetitive use. The microporous membrane with this modified active surface can be a hollow fiber, flat sheet, or other self-supporting shape. The microporous membranes can be used for membrane filtering or a solute and/or solvent exchange process, which involve contacting aqueous-based fluid or blood with the microporous membrane, such processes for dialysis, blood oxygenation, or blood separation filtering, or other processes.
    Type: Application
    Filed: April 26, 2021
    Publication date: August 12, 2021
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Praveen Kosaraju, Monica P. Hall, Jiunn Teo
  • Patent number: 11014051
    Abstract: A method is disclosed for forming a microporous membrane that incorporates an additive having low water solubility at the membrane's active surface from a precipitation fluid. The incorporated additive at the membrane's active surface can improve one or more of the membrane's hydrophilicity, wettability, anti-fouling behavior, blood compatibility, and stability over long periods of use or repetitive use. The microporous membrane with this modified active surface can be a hollow fiber, flat sheet, or other self-supporting shape. The microporous membranes can be used for membrane filtering or a solute and/or solvent exchange process, which involve contacting aqueous-based fluid or blood with the microporous membrane, such processes for dialysis, blood oxygenation, or blood separation filtering, or other processes.
    Type: Grant
    Filed: September 10, 2018
    Date of Patent: May 25, 2021
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Praveen Kosaraju, Monica P. Hall, Jiunn Teo
  • Publication number: 20210138131
    Abstract: Dialyzer systems can consolidate multiple technologies and functionalities of blood treatment systems in a significantly integrated fashion. For example, this disclosure describes dialyzer systems that include a magnetically driven and magnetically levitating pump rotor integrated into the dialyzer. Such a dialyzer can be used with treatment modules that include a magnetic field-generating pump drive unit. In some embodiments, the dialyzers include pressure sensor chambers with flexible membranes with which corresponding pressure transducers of the treatment modules can interface to detect arterial and/or venous pressures.
    Type: Application
    Filed: November 12, 2020
    Publication date: May 13, 2021
    Inventors: Massimo Earl Fini, Lynn E. Jensen, Alexander Heide, Dejan Nikolic, Arne Peters, Christoph Wiktor, Marina Wenke, Tommy Huang, Dacey John Ryan, Stefan Kreber, Lothar Leick, Dzhuney Terzi, Hendrik Therre, Manfred Weis, Alain Veneroni, Reinhold Reiter, Michele Marini, Davide Benelli, Brad Yang, Jiunn Teo
  • Patent number: 10961340
    Abstract: A method forming a surface modifying composition with reduced need for organic solvent and evaporation thereof for removal of insoluble reaction byproducts from the composition. The purified composition can be used in the formation of articles having improved biocompatibility, such as medical articles (e.g., spun hollow fiber).
    Type: Grant
    Filed: July 12, 2018
    Date of Patent: March 30, 2021
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Jiunn Teo, Craig Kamerath, Praveen Kosaraju, Monica P. Hall
  • Publication number: 20210017340
    Abstract: A polysulfone-urethane copolymer is disclosed, which can be used as a membrane polymer, e.g., a matrix polymer, a pore forming agent, or both, while enhancing a membrane's blood compatibility. Methods are disclosed for forming the copolymer and incorporating the copolymer in membranes (e.g., spun hollow fibers, flat membranes) and other products.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 21, 2021
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Geoffrey Russell, James White, Jiunn Teo, Kevin Hudson, Monica Hall, Praveen Kosaraju
  • Patent number: 10822461
    Abstract: A polysulfone-urethane copolymer is disclosed, which can be used as a membrane polymer, e.g., a matrix polymer, a pore forming agent, or both, while enhancing a membrane's blood compatibility. Methods are disclosed for forming the copolymer and incorporating the copolymer in membranes (e.g., spun hollow fibers, flat membranes) and other products.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: November 3, 2020
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Geoffrey Russell, James White, Jiunn Teo, Kevin Hudson, Monica Hall, Praveen Kosaraju
  • Publication number: 20190106545
    Abstract: A polysulfone-urethane copolymer is disclosed, which can be used as a membrane polymer, e.g., a matrix polymer, a pore forming agent, or both, while enhancing a membrane's blood compatibility. Methods are disclosed for forming the copolymer and incorporating the copolymer in membranes (e.g., spun hollow fibers, flat membranes) and other products.
    Type: Application
    Filed: September 28, 2018
    Publication date: April 11, 2019
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Geoffrey Russell, James White, Jiunn Teo, Kevin Hudson, Monica Hall, Praveen Kosaraju
  • Publication number: 20190076787
    Abstract: A method is disclosed for forming a microporous membrane that incorporates an additive having low water solubility at the membrane's active surface from a precipitation fluid. The incorporated additive at the membrane's active surface can improve one or more of the membrane's hydrophilicity, wettability, anti-fouling behavior, blood compatibility, and stability over long periods of use or repetitive use. The microporous membrane with this modified active surface can be a hollow fiber, flat sheet, or other self-supporting shape. The microporous membranes can be used for membrane filtering or a solute and/or solvent exchange process, which involve contacting aqueous-based fluid or blood with the microporous membrane, such processes for dialysis, blood oxygenation, or blood separation filtering, or other processes.
    Type: Application
    Filed: September 10, 2018
    Publication date: March 14, 2019
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Praveen Kosaraju, Monica P. Hall, Jiunn Teo
  • Publication number: 20190016845
    Abstract: A method forming a surface modifying composition with reduced need for organic solvent and evaporation thereof for removal of insoluble reaction byproducts from the composition. The purified composition can be used in the formation of articles having improved biocompatibility, such as medical articles (e.g., spun hollow fiber).
    Type: Application
    Filed: July 12, 2018
    Publication date: January 17, 2019
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Jiunn Teo, Craig Kamerath, Praveen Kosaraju, Monica P. Hall
  • Patent number: 9617421
    Abstract: The present invention relates to the use of additives in processes to form polymeric fibers. These fibers can be formed into membranes with improved middle and/or higher molecular weight solute removal.
    Type: Grant
    Filed: February 3, 2012
    Date of Patent: April 11, 2017
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Cheryl Ford, Jiunn Teo, Leslie Schmidt
  • Patent number: 9353220
    Abstract: A process for making polyarylethers provides a reaction mixture that includes a dipolar aprotic solvent for polyarylether and polyarylether forming reactants, and reacts the polyarylether-forming reactants, with removing of water with nitrogen in the absence of azeotrope forming cosolvent and optionally replacing removed amounts with dipolar aprotic solvent. The process can further include directly wet spinning the reactor solution without recovery of the polymer from the dipolar aprotic solvent through a spinneret to form hollow fibers or flat sheets suitable for membranes.
    Type: Grant
    Filed: August 13, 2013
    Date of Patent: May 31, 2016
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Selvaraj Savariar, Kevin Hudson, Geoffrey Andrew Russell, James Leslie White, Brett Allen Barton, Cheryl Ford, Jiunn Teo
  • Publication number: 20130338297
    Abstract: The present invention relates to the use of additives in processes to form polymeric fibers. These fibers can be formed into membranes with improved middle and/or higher molecular weight solute removal.
    Type: Application
    Filed: February 3, 2012
    Publication date: December 19, 2013
    Inventors: Cheryl Ford, Jiunn Teo, Leslie Schmidt
  • Patent number: RE48703
    Abstract: The present invention relates to the use of additives in processes to form polymeric fibers. These fibers can be formed into membranes with improved middle and/or higher molecular weight solute removal.
    Type: Grant
    Filed: December 27, 2018
    Date of Patent: August 24, 2021
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Cheryl Ford, Jiunn Teo, Leslie Schmidt